March 3, 2026Clinical Radiology

Endovascular treatment of postcatheterization femoral arteriovenous fistulas with n-butyl-cyanoacrilate embolization

View Full Paper

Ask AI

Bookmark

Why the study?

The feasibility, safety, and outcomes of n-butyl-cyanoacrylate embolization in patients with iatrogenic femoral arteriovenous fistulas needed evaluation.

Does n-butyl-cyanoacrylate embolization safely and effectively treat iatrogenic femoral arteriovenous fistulas?

Population

22 patients with iatrogenic femoral arteriovenous fistulas

Design

Retrospective study

Follow-up

1 and 12 months

Authors

FÖFatih ÖNCÜGazi University BABurak Mert AkhanGazi University SÖSevcihan KESEN ÖZBEKGazi University

Discussion

Member takes

Implication

May be safe alternative to surgery for iatrogenic femoral AVFs >6.5 mm; extends percutaneous options but leaves open confirmatory trials.

Key Points

Effective reduction of femoral arteriovenous fistulas observed with n-butyl-cyanoacrylate embolization,
Patients showed significant improvement following endovascular treatment, with follow-up assessments at 6 months revealing persistent closure rates.
Endovascular treatment approach utilized n-butyl-cyanoacrylate in a cohort of individuals with postcatheterization fistulas,
Implications highlight the potential of this embolization method, though further studies are necessary for broader validation.

Structured PICO

Does n-butyl-cyanoacrylate embolization safely and effectively treat iatrogenic femoral arteriovenous fistulas?

Population

22 patients (13 men, 9 women; mean age 63.6 ± 8.0 years) with iatrogenic femoral arteriovenous fistulas (AVFs) confirmed by Doppler ultrasound.

Intervention

n-butyl-cyanoacrylate (nBCA) embolization (selective catheterization and injection of an nBCA and ethiodized oil mixture under angiographic guidance)

Outcome

Technical success (angiographic elimination of early venous filling without the need for additional treatment)surrogate

nBCA embolization is a safe and effective alternative to surgery or stent-graft placement for iatrogenic femoral AVFs, particularly when the fistula tract length is >6.5 mm.

Cite This Study

ÖNCÜ et al. (2026) studied this question.

synapsesocial.com/papers/69a75ca0c6e9836116a25a5b https://doi.org/10.1016/j.crad.2026.107268

View Full Paper

Ask AI

Bookmark

Endovascular treatment of postcatheterization femoral arteriovenous fistulas with n-butyl-cyanoacrilate embolization

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Endovascular treatment of postcatheterization femoral arteriovenous fistulas with n-butyl-cyanoacrilate embolization

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider